BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference
BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium
Maritime Resources: A Low-risk Path to Gold Production in One of the World’s Top Mining Jurisdictions
Homerun Resources Inc. Announces New Homerun Energy Website and "The Hub" AI-Powered Platform for Energy Management
